Ernexa Therapeutics Inc. reports

Company location: Cambridge, MA
Fiscal year end: 31 December

Ernexa Therapeutics Inc. has filed 1,510 SEC EDGAR filings since 14 Feb 1994

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 376-400 of 1,000 matching filings.

Per page

Current page

8-K File 001-11460

8-K

Filing date: 15 Apr 2021
Reporting date: 09 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-11460

8-K

Filing date: 07 Apr 2021
Reporting date: 01 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 3

Filing date: 05 Apr 2021
Reporting date: 25 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 3

Filing date: 05 Apr 2021
Reporting date: 25 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 3

Filing date: 05 Apr 2021
Reporting date: 25 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 3

Filing date: 05 Apr 2021
Reporting date: 25 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-11460

8-K

Filing date: 31 Mar 2021
Reporting date: 25 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 26 Mar 2021
Reporting date: 24 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

FORM 4

Filing date: 26 Mar 2021
Reporting date: 24 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-11460

8-K filing

Filing date: 23 Mar 2021
Reporting date: 23 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 22 Mar 2021
Reporting date: 19 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 22 Mar 2021
Reporting date: 19 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date: 17 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-42217

AMENDMENT NO. 3

Filing date: 17 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-42217

AMENDMENT NO. 2

Filing date: 16 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-11460

8-K filing

Filing date: 16 Mar 2021
Reporting date: 15 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-11460

10-K filing

Filing date: 11 Mar 2021
Reporting date: 31 Dec 2020
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-11460

8-K filing

Filing date: 08 Mar 2021
Reporting date: 08 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

425 File 001-11460

425 filing

Filing date: 08 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-11460

8-K filing

Filing date: 26 Feb 2021
Reporting date: 26 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

425 File 001-11460

425 filing

Filing date: 26 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-11460

8-K filing

Filing date: 25 Feb 2021
Reporting date: 25 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

425 File 001-11460

425 filing

Filing date: 25 Feb 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 22 Feb 2021
Reporting date: 19 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4 filing

Filing date: 22 Feb 2021
Reporting date: 19 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing